GPC
40
2
RRC
60
-3
NOC
40
-10
KSS
42
-3
DD
61
4
VNO
60
8
XEL
65
-2
CHRW
67
3
XRX
34
-3
BLK
70
-2
NI
73
3
DOV
73
4
CF
53
2
MA
67
-5
JBHT
63
-5
KO
44
2
STI
31
19
TXN
49
-6
HCP
70
-4
WDC
38
-3
GPC
40
2
RRC
60
-3
NOC
40
-10
KSS
42
-3
DD
61
4
VNO
60
8
XEL
65
-2
CHRW
67
3
XRX
34
-3
BLK
70
-2
NI
73
3
DOV
73
4
CF
53
2
MA
67
-5
JBHT
63
-5
KO
44
2
STI
31
19
TXN
49
-6
HCP
70
-4
WDC
38
-3
Financhill
Back

Dyne Therapeutics Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Buy
66

DYN
Dyne Therapeutics

Last Price:
30.92
Seasonality Move:
38.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Dyne Therapeutics Price Quote

$30.92
-3.22 (-9.43%)
(Updated: November 14, 2024 at 2:05 PM ET)

Dyne Therapeutics Key Stats

Buy
66
Dyne Therapeutics (DYN) is a Buy
Day range:
$29.02 - $35.68
52-week range:
$9.26 - $47.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.81%
Volume:
2.2M
Avg. volume:
934K
1-year change:
292.41%
Market cap:
$2.9B
Revenue:
$0
EPS:
$-3.59

How Much Does Dyne Therapeutics Make?

Data Unavailable

Is Dyne Therapeutics Growing As A Company?

Data Unavailable

Dyne Therapeutics Stock Price Performance

  • Did Dyne Therapeutics Stock Go Up Last Month?
    Dyne Therapeutics share price went up by 1.4% last month
  • Did DYN's Share Price Rise Over The Last Year?
    DYN share price rose by 292.41% over the past 1 year

What Is Dyne Therapeutics 52-Week High & Low?

Dyne Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Dyne Therapeutics?

  • How Much Debt Does Dyne Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Dyne Therapeutics Have?
    Cash and short term investments quarterly total is $778.8M
  • What Is Dyne Therapeutics’s Book Value Per Share?
    Book value per share is 7.74

Is Dyne Therapeutics Cash Flow Positive?

  • What Is DYN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$219M
  • What Is Dyne Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $788.9M
  • What Is Dyne Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$129.6M

Dyne Therapeutics Return On Invested Capital

Data Unavailable

Dyne Therapeutics Earnings Date & Stock Price

Dyne Therapeutics Competitors

  • Who Are Dyne Therapeutics's Competitors?
    Below is a list of companies who compete with Dyne Therapeutics or are related in some way:
    • Capricor Therapeutics Inc (CAPR)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Novavax Inc (NVAX)
    • Regenxbio Inc (RGNX)
    • Sarepta Therapeutics Inc (SRPT)

Dyne Therapeutics Dividend Yield

Dyne Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -34.95%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 52.20
Upside from Last Price: 52.9%

Major Shareholders

  • How many DYN shares are owned by institutional investors?
    142.3M DYN shares are owned by institutional investors
  • How many DYN shares are owned by insiders?
    2M DYN shares are owned by insiders